Supreme Court Ruling on Gender-Affirming Care
Justice Clarence Thomas expressed skepticism on Wednesday, suggesting that the Supreme Court should avoid deferring to a so-called “self-explanatory expert” regarding gender-affirming care. He indicated that the issue is fraught with medical uncertainty.
This statement came as the court upheld a 6-3 ruling that prohibits Tennessee from using adolescent blockers and hormonal treatments for transgender minors.
Thomas noted in his opinion, “There is a simple lesson in this case. In politically controversial discussions surrounded by scientific uncertainty, courts should not assume that self-explained experts are correct.”
The Tennessee law, known as SB 1, prohibits healthcare providers from prescribing any drugs for puberty blocking and hormone therapy to minors. Enacted in 2023, it also bans gender transition surgeries for minors, although Thomas did not address that aspect in his comments.
Violating this law could result in a civil penalty of $25,000 for healthcare providers.
While acknowledging a general consensus among many prominent medical professionals on how to approach gender discomfort in children, Thomas suggested that there is growing evidence contradicting these views. He argued that certain experts overlook critical issues that challenge the notion that young children can consent to “irreversible treatment.”
He claimed that those in the field have shaped medical recommendations to further their political aims. Joining the majority opinion, Thomas emphasized that the court’s decisions will endure for both Americans and their elected officials.
This ruling dismisses challenges from the administration of former President Biden. Advocates for LGBTQ rights argued that Tennessee’s law represents discrimination, warranting a higher level of constitutional scrutiny and an appeal to repeal similar laws.
Justice Sonia Sotomayor voiced her dissent, countering Thomas’s assertions in her footnotes. She wrote, “It’s far from showing that ‘self-proclaimed experts’ can determine the ‘meaning of the Constitution.’ This reference to established healthcare institutions is merely one context relevant to the court’s evaluation of whether SB 1 substantially aligns with significant government interests.”
Sotomayor also pointed out that Thomas seems aware of some scientific and medical evidence that ties into the case, as he referenced peer-reviewed medical journals in his opinion.
After President Trump resumed office, his Justice Department withdrew the Biden administration’s challenge. Still, the new administration pressed the Supreme Court to address the case, underscoring its significance.
Major healthcare organizations, including the American Medical Association, assert that gender-affirming care is medically essential and can often be life-saving, though access to such care varies significantly among trans individuals.
Meanwhile, reports from the Ministry of Health and Human Services questioned the scientific basis for gender-affirming treatments. Susan J. Cresley, the president of the American Academy of Pediatrics, voiced concern, stating her organization is “deeply wary” of misinformation that fails to represent current pediatric care realities.
In recent oral discussions, Justices Samuel Alito and Brett Kavanaugh referenced European nations that have begun to restrict gender-affirming care for youth, insinuating that such trends should caution the court’s approach.
However, critics of the U.S. laws restricting transition-related care argue that the bans imposed by Republican-led states far exceed any measures taken in Europe.
Pratik Shah, a Supreme Court officer, criticized Tennessee’s law, stating, “This is not a normal medical regulation,” during a conversation with reporters in December.
